جست‌وجوی استاد و پژوهشگر

• Cardiogenomics
• Cardiovascular Disease
• Women's Health
• +۴ مورد دیگر

Anja Bye is a Professor and Research Group Leader at the Department of Circulation and Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU). She also serves as a Research Advisor at St. Olav's Hospital's Research Department and Study Program Leader for Pain and Complex Disorders in the Master's program in Clinical Health Sciences at NTNU. Education: Master of Science in Biotechnology (NTNU) Doctorate in Molecular Medicine (NTNU) Research Interests: Her work focuses on cardio-metabolic diseases with a gender lens, particularly in women. Key areas include cardiogenomics, biomarker discovery (microRNA, lipoproteins), genetic determinants of fitness, and translational research linking exercise physiology to cardiovascular health. Collaborations span institutions like Karolinska Institutet, University of Milan, and St. Olav's Hospital. Publications: Over 40 peer-reviewed articles since 2008, emphasizing microRNA-based risk prediction, genetic fitness determinants, and lipidomics in cardiovascular disease. Recent work includes polygenic prediction models and biomarker validation studies. Awards: None explicitly listed in provided text. Advising/Grants: Supervises 4 master's students, 4 fellows, and 1 postdoc. Projects include CorFemina (women's heart disease prevention), CardioFit (genetic fitness studies), and LipidEx (exercise in lipedema). Active in securing multi-institutional grants for interdisciplinary cardiovascular research. Labs/Teams: Leads the Cardiogenomics Research Group and collaborates with the Cardiac Exercise Research Group. Coordinates multi-disciplinary teams in clinical intervention studies and molecular epidemiology.

• Genomics
• Personalized Medicine
• Translational Medicine
• +۳ مورد دیگر

Jenny Taylor is a Professor at the University of Oxford , serving as Programme Director for the Genomic Medicine Theme within the Nuffield Department of Medicine and affiliated with the Wellcome Trust Centre for Human Genetics . Her work bridges genetics research with clinical applications through the Oxford Biomedical Research Centre , focusing on translational medicine and NHS integration. Focuses on genomics and personalized medicine Develops genomic technologies for clinical diagnostics Collaborates with Oxford University Hospitals Trust Integrates research into bedside clinical practice Her research emphasizes whole-genome sequencing , gene panels for cancer diagnostics, and non-coding variant interpretation . Projects span heart disease , leukaemia , cancer , and neurodegenerative conditions , with recent publications analyzing circulating tumor DNA, structural variants in developmental disorders, and computational drug design. Recent 15 articles (2022-2025) demonstrate expertise in genomic diagnostics for rare diseases, splice variant analysis , and non-coding mutation interpretation . Collaborative work in cancer genomics , neurodevelopmental disorders , and structural variation detection highlights translational impact.

Dumitru A. Iacobasمشاهده پروفایل

استادیار مهمان

• Neurogenomics
• Cardiogenomics
• Cancer Genomics
• +۳ مورد دیگر

Dumitru A. Iacobas is a Visiting Assistant Professor at the Dominick P. Purpura Department of Neuroscience, affiliated with Prairie View A&M University's R.G.P. College of Engineering. His research spans neurogenomics, cardiogenomics, cancer genomics, and mathematical modeling of complex biosystems, focusing on gene regulatory networks and intercellular signaling mechanisms. Core Research: Identifying gene master regulators for cancer therapy, characterizing genomic fabric topology in disease states, and modeling calcium signaling in complex tissues Methodologies: Developed computational tools for transcriptomic analysis and patented micro-pipette fabrication techniques Publication Trends: Recent work emphasizes neurological diseases, cancer biomarkers, and systems biology approaches, with a 2025 special issue on neurogenomic fabric in brain disorders His academic contributions include foundational books on biophysics and pharmacology, alongside numerous patents from the 1980s-1990s related to electrophysiological instrumentation.

Jelle Vlaeminckمشاهده پروفایل

پژوهشگر

• Oncogenetics
• Cardiogenetics
• Pharmacogenetics
• +۴ مورد دیگر

Jelle Vlaeminck is a molecular geneticist and Researcher at Vrije Universiteit Brussel, specifically within the Department of Medical Genetics at UZ Brussel (University Hospital Brussels). He holds a PhD in Medical Sciences and works as an external employee in Clinical Sciences and Genetics Reproduction and Development. His professional activities span across research, diagnostics, and academic supervision within the field of human genetics and medicine. Dr. Vlaeminck's primary research interests encompass oncogenetics (cancer genetics), cardiogenetics (hereditary heart diseases), and pharmacogenetics (genetic impact on drug metabolism), all situated within the broader framework of personalized medicine. A significant focus of his work involves clarifying genetic variants of unknown significance (VUS) to determine their pathogenic potential, thereby improving patient care and management. He is a founding member of the CLARITY project (Clarifying the functional effect of genetic variants of unknown significance for improved patient therapy), which specifically addresses VUS research. His work extends to diagnostic analyses including NIPT and gene panel analyses. The research output of Dr. Vlaeminck demonstrates a strong focus on variant interpretation, particularly in cancer-related genes like BRAF and MET proto-oncogenes, as well as in rare genetic disorders like desmin-related myofibrillar myopathy. His publications reveal a consistent pattern of investigating variants of unknown significance across multiple genetic contexts, with applications in diagnosis, prognosis, and treatment selection. The research shows interdisciplinary collaboration across oncology, cardiology, and neurology domains. Belgian Society for Human Genetics (BeSHG) Belgian Society of Cardiology (BSC) Belgian Council on Cardiogenomics (BELCARGEN) European Society of Cardiology (ESC) ESC Council on Cardiovascular Genomics Belgian PGx interest group (WG3) Dr. Vlaeminck actively supervises master's students, as evidenced by his involvement in thesis projects related to variant analysis and splicing mechanisms. His professional activities include participation in numerous conferences and workshops, including the European Partnership for Personalised Medicine conference, European Society of Human Genetics Training Course on Cardiogenetics, and various specialized meetings in oncology and cardiogenomics. His research appears to be conducted within collaborative networks focused on personalized medicine and genetic diagnostics.

• Cardiogenomics
• Cardiovascular Disease
• Genetics
• +۳ مورد دیگر

Anja Bye is a Professor and head of the interdisciplinary Cardiogenomics research group at the Norwegian University of Science and Technology (NTNU). Her primary affiliation is with the Department of Circulation and Imaging, which is part of the Faculty of Medicine and Health Sciences. She leads research initiatives within the Cardiac Exercise Research Group (CERG), focusing on precision cardiac care through genomic and genetic analysis. Her main research projects include CorFemina , addressing sex-specific disparities in cardiovascular disease (CVD) prevention and treatment for women, and CardioFit , investigating the genetic determinants of aerobic fitness and its causal role in CVD development. She emphasizes integrating multi-omics data (genomics, transcriptomics, proteomics, metabolomics) with clinical outcomes to better understand CVD pathogenesis and improve diagnostic and therapeutic strategies. Key Competencies: Cardiovascular disease, clinical research, genetic epidemiology, biomarkers, lipidomics, metabolomics, microRNA, and Mendelian randomization. Research activities include developing CVD risk prediction algorithms for women, exploring molecular mechanisms for gender-specific drug targets, and leveraging large-scale cohorts like the HUNT study. She advocates for personalized CVD prevention, especially targeting women's underrepresentation in clinical studies. She oversees the Cardiogenomics group within CERG, fostering interdisciplinary collaboration to advance genomic applications in cardiology. No specific grants or awards are explicitly listed in the provided text, though her work builds on foundational discoveries like the Nobel Prize-winning LDL receptor research referenced in her background.

• Cardiogenomics
• Cardiac Exercise Physiology
• Lipoprotein Biology
• +۳ مورد دیگر

Julie Caroline Sæther is a researcher at the Norwegian University of Science and Technology (NTNU), affiliated with the Department of Circulation and Medical Imaging under the Faculty of Medicine and Health Sciences. Her research focuses on cardiogenomics, cardiac exercise physiology, and lipid metabolism, particularly in the context of atherosclerosis and myocardial infarction risk prediction. She has contributed to studies utilizing the HUNT cohort and advanced imaging techniques like near-infrared spectroscopy (NIRS) to identify novel biomarkers. Her work bridges lipidomics, molecular cardiology, and clinical epidemiology. Key research areas include lipid subfraction analysis (e.g., LDL-5), microRNA signaling pathways, and non-invasive assessment of coronary plaque composition. She collaborates with institutions like AHL-senteret and has presented findings at conferences such as the European Society of Cardiology and ESC Preventive Cardiology. Her interdisciplinary approach integrates genomic data with clinical outcomes to improve cardiovascular risk stratification. Publications emphasize biomarker validation, lipid profile associations with atherosclerosis, and the role of cardiorespiratory fitness in lipid-related cardiovascular risks. Her research aims to translate molecular discoveries into clinical tools for early disease detection and prevention.

Erik Carterمشاهده پروفایل

استادیار بالینی

• Cardiac ion channelopathies
• Genetics
• Epigenetics
• +۷ مورد دیگر

Dr. Erik Carter is a Clinical Assistant Professor and Director of Undergraduate Programs at Wayne State University. With extensive clinical expertise in acute and critical care cardiovascular nursing , he bridges social action , health equity , and innovative teaching in nursing education. University of California, San Francisco: PhD in Nursing (2015), MS in Cardiogenomics (2008) Research Interests focus on cardiac ion channelopathies , gene-environment interactions , and social determinants of health , with recent work on DNA methylation and health disparities in heart transplantation. His teaching innovations emphasize clinical judgment , andragogic principles , and technology integration for undergraduate nursing students. Publications highlight cardiovascular genetics , social justice , and interprofessional education . His 2025 work explores colorectal cancer disparities and opioid prevention in Metro Detroit, while 2016-2018 studies focus on ECG biomarkers in heart transplant rejection. Scientific Awards AACN Educational Advancement Scholarship (2006-2008) AACN/CE Minority Faculty Scholarship (2006-2010) UCSF SON Dean’s Fellowship (2008-2010) CTSI NIH TL1 Fellow (2010-2011) Dr. Marquita Chamblee Community Impact Award (2025) As a human rights commissioner in Detroit, he advocates for health equity through community outreach and public health initiatives . He teaches courses like NUR 4060: Transition to Nursing Practice and NUR 4660: Health Literacy , aligning with his mission to address health compliance and social determinants .

• Cardiology
• Cardiac Electrophysiology
• Catheter Ablation
• +۴ مورد دیگر

Giulio Conte is an Adjunct Professor of Medicine at the Università della Svizzera italiana (USI) and an Honorary Visiting Professor of Medicine at Vrije Universiteit Brussel (VUB). He works as a senior consultant cardiologist and physician head (Caposervizio) for Electrophysiology/Rare Cardiovascular Diseases at Cardiocentro Ticino Institute in Lugano, Switzerland, since 2014. Ph.D. in Medical Sciences University Master in Cardiac Electrophysiology His research focuses on catheter ablation , computer modeling of atrial fibrillation , inherited arrhythmia syndromes , and cardiogenomics . He has authored over 160 peer-reviewed articles and secured 1.5 Mio EUR in research grants. Scientific Awards & Grants: Swiss National Foundation Swiss Heart Foundation European Commission Boston Scientific Inc.